JSC Research and Industrial Center Borschahivka chemical and pharmaceutical plant plans by the end of 2018 to invest UAH 176 million, including in the completion of the upgrade of the new production line. “We invested UAH 76.9 million in development in 2017. Until the end of 2018, we intend to invest UAH 176 million in the production update. This money will go, including, to complete the construction of a new site for the production of pills and capsules, the launch of which is scheduled for 2019,” Director General of the plant Yulia Zdarevska told Interfax-Ukraine.
She said that the capacity of the new workshop will be 500 million pills and capsules, which will increase the total production capacity of these dosage forms by 27%.
Zdarevska also said that in the fourth quarter of 2020, the plant plans to put into operation a finished goods warehouse for 5,000 pallet positions.
In addition, the company plans to reconstruct the department of sterile antibiotics and a site for the production of medicines in vials, and intends to expand the capacity of the production site of lyophilic preparations.
“The renovation of equipment is only one of the components of the development of the plant in general. The purchase of new equipment and software is necessary, because we plan to expand production and output new products both to the domestic market and to foreign ones,” the plant’s director general said.
In addition, she recalled the company’s plans to expand the geography of exports and establish relations with foreign partners, invest in the development and conduct of research.
Currently, the plant’s medicines are manufactured in five main workshops, each of which fully complies with GMP standards, and production lines are equipped with modern high-tech equipment from leading European companies.
The Ukrainian market needs three or five years to fully launch the QR code system for packages of medicines, Commercial Director of Research and Industrial Center Borschahivka chemical and pharmaceutical plant Yevhen Sova has said. “The implementation of the new rules is a step in right direction, but it is a long process, which should be prepared and introduced in phases. The Ukrainian market would require from three to five years to organically introduce the changes,” he told Interfax-Ukraine.
Sova said that the introduction of QR codes for packages would allow helping in fight against counterfeit medicines.
“We are preparing for this at Borschahivka chemical and pharmaceutical plant. The enterprise has installed specialized equipment for placing QR codes on packages,” he said.
The expert said that the monitoring system using QR codes would work only the general public approach at all levels of flow of medicines would apply.
Sova said that the introduction of QR codes on the Ukrainian pharmaceutical market could affect the cost of medicines.
PJSC Research and Industrial Center Borschahivka chemical and pharmaceutical plant has filed a lawsuit to Kyiv’s business court against PrJSC Darnitsa pharmaceutical firm (both based in Kyiv) and a lawsuit against the municipal ownership department of the Kyiv City Council, seeking to declare invalid a trading session where shares in the plant were sold and the respective sale and purchase contract was signed. “After studying the materials of the lawsuit, the court declared them sufficient for accepting the lawsuit, opening the proceeding and hearing the case,” the business court said in a ruling published in the unified register of court rulings.
In turn, Darnitsa pharmaceutical firm filed the counterclaim against Borschahivka chemical and pharmaceutical plant seeking to declare valid its ownership rights to the shares of the plant.
Four persons also filed lawsuits to the business court of Kyiv with the same demands against Darnitsa pharmaceutical firm and the municipal ownership department of the Kyiv City Council.
